Skip to main content
Kwangdong Healthbio Co., Ltd. logo

Kwangdong Healthbio Co., Ltd. — Investor Relations & Filings

Ticker · 086220 ISIN · KR7086220001 KO Manufacturing
Open in API
Filings indexed 143 across all filing types
Latest filing 2026-03-30 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 086220

About Kwangdong Healthbio Co., Ltd.

http://www.kd-healthbio.com

Kwangdong Healthbio Co., Ltd. develops, manufactures, and sells a range of health-focused products. The company's portfolio primarily consists of health functional foods, nutritional supplements, and general food products. Key offerings include vitamins, calcium, glucosamine, and weight management aids. In addition to its food and supplement lines, the company also produces and distributes cosmetic and personal care items, such as hair care products. The business is involved in the development of biologically engineered products aimed at enhancing consumer well-being.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 65% confidence The document is a statutory disclosure filed with the Korean Financial Services Commission/KRX regarding the grant and correction of stock options (주식매수선택권 부여). It details changes in the number of options granted, exercise conditions, and fair‐value assumptions. This is not an earnings release, management discussion, or legal proceeding, nor is it an insider trade or dividend notice. It constitutes an announcement of new share issuance rights (options) and thus relates to a change in capital structure. Therefore, it best fits the “Share Issue/Capital Change” category (SHA).
2026-03-30 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 75% confidence The filing is a statutory notification (“신고”) of the grant (and correction) of employee stock options (“주식매수선택권 부여”). This is an announcement of a planned equity issuance (capital change) under the company’s option plan rather than a full annual or interim report, insider trade, or other category. It best maps to “Share Issue/Capital Change”.
2026-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is titled “정기주주총회 결과” (Annual General Meeting results) and details voting outcomes on agenda items, including approval of financial statements, changes to the articles, board appointments, and compensation limits. This is a formal announcement of shareholder vote results at the AGM, matching Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-03-24 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 33rd fiscal year (2025), covering the period from January 1, 2025, to December 31, 2025. It contains detailed company information, financial data, management discussion, and operational details, which are characteristic of an Annual Report (10-K equivalent in the Korean regulatory context). FY 2025
2026-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal notification titled '감사보고서 제출' (Submission of Audit Report) filed by Kwangdong Health Bio. It provides a summary of the audit opinion, key financial data (assets, liabilities, revenue, profit/loss), and the name of the accounting firm. While it contains financial data, it is a regulatory filing announcing the submission of the audit report to the exchange, rather than the full annual report or a standalone audit document. Given the structure and the nature of the announcement, it fits the 'Report Publication Announcement' (RPA) category as it notifies the market of the availability of the audit report. FY 2025
2026-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Gwangdong Health Bio Co., Ltd. It contains the meeting agenda, details on voting procedures (including electronic voting), and management information such as board activities and financial statements for the 33rd fiscal year. This type of document, which provides information to shareholders to solicit their votes for an upcoming meeting, is classified as a Proxy Solicitation & Information Statement.
2026-03-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.